Calculation of residence times and radiation doses using the standard PC software Excel

European Journal of Nuclear Medicine

Volumn 24, Issue 12, 1997, Pages 1514-1521

  Herzog, H ^a   Zilken, H ^a   Niederbremer, A ^a   Friedrich, W ^a   Muller Gartner H W ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Excel; MIRDOSE3; Radiation dosimetry; Residence times

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ARTICLE; COMPUTER PROGRAM; DOSE CALCULATION; MICROCOMPUTER; RADIATION DOSE;

ADULT; ANIMALS; CARBON RADIOISOTOPES; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MICROCOMPUTERS; RADIATION DOSAGE; RADIATION PROTECTION; RADIOMETRY; RADIOPHARMACEUTICALS; SOFTWARE; TIME FACTORS;

EID: 0031434957     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050182     Document Type: Article

References (18)

1. Loevinger R, Budinger, TF, Watson EE. MIRD-Primer for absorbed dose calculations. New York: The Society of Nuclear Medicine, 1988.
2. Snyder WS, Ford MR, Warner GG; et al. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. New York, The Society of Nuclear Medicine, 1975.
3. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26, Pergamon Press, 1977.
4. Recommendations of the International Commission on Radiological Protection. ICRP Publication 60, Pergamon Press, 1991.
5. 4 receptors in the living primate brain. J Nucl Med 1996; 37: 113P.
6. Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Quantitation of the whole-body distribution of PET radiopharmaceuticals: applied to 3-N-([18F]fluoroethyl)spiperone. Eur J Nucl Med 1990; 16: 77-83.
7. Herzog H, Seitz RJ, Tellmann L, Schlaug G, Kleinschmidt A, Nebeling B, Stöcklin G, Müller-Gärtner HW. Pharmacokinetics and radiation dose of oxygen-15 labelled butanol in rCBF studies in humans. Eur J Nucl Med 1994; 21: 138-143.
8. Budinger TF. Quantitative nuclear medicine imaging: application of computers to the gamma camera and whole-body scanner. Recent Adv Nucl Med, 1974: 41-130.
9. Sorensen JA. Quantitative measurement of radioactivity in vivo by whole-body counting. In: Hine GJ, Sorensen JA eds. Instrumentation in nuclear medicine, vol. 2. New York: Academic Press; 1974; 311-347.
10. Herzog H, Spohr G, Notohamiprodjo G, Feinendegen LE. Absolute quantification of pharmacokinetic distribution of RES colloids in individuals with normal liver function. Nucl Med Commun 1987; 8: 157-175.
11. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996, 37: 538-546.
12. Cloutier RJ, Smith SA, Watson EE, et al. Dose to the fetus from radionuclides in the bladder. Health Phys 1973; 25: 147-161.
13. 18F]fluoro-L-dopa. J Nucl Med 1985; 26: 931-935.
14. Wong DF, Bice AN, Beck T, Dannals RF, Links JM, Wagner HN. Dosimetry calculations for the neuroreceptor binding radiotracer C-11 N-methylspiperone [abstract]. J Nucl Med 1986; 27: 898.
15. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S: Estimation of absorbed dose in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 1991; 32: 699-706.
16. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53. Pergamon Press, 1988.
17. 123I]iodo-α-methyltyrosine. Eur J Nucl Med 1997; 24: 1162-1166.
18. Berg L. Über Gaußsche Markov-Prozesse als Wachstumsmodelle. Biometrical J 1981; 23: 477-486.